| Sepracor Inc. - [Ticker: SEPR]|| |
|Última Trade||Range 52 Semanas||[0,000 - 0,000]|
|Hora da Última Trade||N/A - N/A||Price-Target 1 Ano||N/A|
|Variação|| ()||Capitalização Bolsista||3 |
|Bid / Ask||N/A||EPS||0,00|
|Volume||Volume Médio (3m)||0|
|Nota: Os dados podem apresentar atraso de alguns minutos.|
|Ver cotações de outros activos|
|Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:|
|Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..|
| Notícias sobre Sepracor Inc. [SEPR]: (ordenadas por relevância)|
Allergy Treatment Market Research Report: Quantitative Market Analysis, Current and Future Trends, 2024Digital Journal... Meda Pharmaceuticals, Inc., Allergan plc, Schering-Plough Corporation, Alerpharma S.A., McNeil Consumer Healthcare, Allergopharma, Genentech, Inc., Allergon AB, Collegium Pharmaceutical, Inc., and Sepracor, Inc. These companies have been looking ...e mais »
Allergy Treatment Market : Trends, Outlook and Opportunity Analysis 2024Digital Journal... Meda Pharmaceuticals, Inc., Allergan plc, Schering-Plough Corporation, Alerpharma S.A., McNeil Consumer Healthcare, Allergopharma, Genentech, Inc., Allergon AB, Collegium Pharmaceutical, Inc., and Sepracor, Inc. These companies have been looking ...
Flex Pharma (FLKS) Names William McVicar President and cEOStreetInsider.com... Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps and spasticity associated with severe neurological diseases including multiple sclerosis (MS), Charcot-Marie-Tooth (CMT ...e mais »
Flex Pharma Reports Second Quarter 2017 Financial ResultsBusiness Wire (press release)The INC is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research in CMT and to improving the care of patients (www.rarediseasesnetwork.org/cms/inc ...e mais »
Desloratadine Market Key Players, Industry Overview, Supply and Consumption Demand Analysis to 2021satPRnews (press release)Desloratadine Market Key Players Analysis: Pfizer, Teva, Wante Pharmaceutical?, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...
PR Newswire (press release)
Genzyme Corporation Pays $5.885 Million To Resolve False Claims Act Allegations; Judgment Involving Cases ...PR Newswire (press release)Those defendants include Allergan, Inc., Amgen, Inc., Bradley Pharmaceuticals, Inc., Eisai, Inc., Mallincrodt, Inc., Novo Nordisk, Inc., Reliant Pharmaceuticals, Inc., Sepracor, Inc., and Upsher-Smith Laboratories, Inc. The settlement with Genzyme ...e mais »
Dainippon to buy US drug firm Sepracor for $2.6 billionReutersBOSTON/TOKYO (Reuters) - Dainippon Sumitomo Pharma Co Ltd agreed on Thursday to buy U.S. drugmaker Sepracor Inc for $2.6 billion, giving the Japanese firm a big, local sales force in the world's largest drugs market. The deal is the latest in a string ...
Sunovion Pharmaceuticals Inc. Announces Company Name ChangeBusiness Wire (press release)BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by ...e mais »
Sunovion Celebrates Five-Year Anniversary MilestoneBusiness Wire (press release)MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that it is celebrating its five-year anniversary. Sunovion was established in October 2010 following the integration of Sepracor Inc. and Dainippon ...e mais »
|Para mais notícias sobre Sepracor Inc. clique aqui:|
Notícias de Sepracor Inc.
Largura do Site:
Imagem de Fundo: